About IMMUNEXPRESS INC.
Immunexpress is a privately-owned company developing molecular diagnostic tools for sepsis detection through immune response analysis, offering rapid results in one hour using the SeptiCyte® RAPID technology. Their mission is to empower clinicians and patients in managing sepsis, a leading cause of hospital deaths and costs.
Rapid sepsis detection through immune response analysisDevelopment of molecular diagnostic tools for sepsis managementProduction of SeptiCyte® RAPID, a fully automated diagnostic cartridge compatible with the Biocartis Idylla™ platformAnalysis of molecular blood biomarkers from a patient’s immune system
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| Federal contract award | Department of Health and Human Services | $750K |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to IMMUNEXPRESS INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.